Indywidualna Praktyka Lekarska prof. Konrad Rejdak

Lublin 20-410

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis — Running, not enrolling
• Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis — Completed